- Last two weeks of the quarter impacted by the COVID-19 pandemic
- Sales of $3,988.9 million, up 7.8% and 8.1% when excluding the impact of IFRS 16
- Food same-store sales up 9.7%, and up 5.2% excluding COVID-19 impact
- Pharmacy same-store sales up 7.9%, and up 6.4% excluding COVID-19 impact
- Net earnings of $176.2 million, up 45.0% and adjusted net earnings(1)
- Fully diluted net earnings per share of $0.69, up 46.8% and adjusted fully diluted net earnings per share(1) of $0.72, up 20.0%
- Impact of COVID-19 represents an increase in net earnings per share of about $0.03
Please look at our Press Release (.pdf)
